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The effects of Neuropeptide Y on in 
ulti unit· in the 
ay 
Communication between various systems in the human body is essential to 
produce homeostasis. The key messengers in this complicated network of coordinated 
systems are neurotransmitters. These molecules are responsible for relaying information 
to muscles cells and peripheral neurons to illicit appropriate responses. Neuropeptide 
Y(NPY) is an example of a neurotransmitter that is pervasive throughout the body. It has 
wide ranging effects, but one recurring theme is that it functions by enhancing the effects 
caused by uradrenoceptor agonists. However, vasoconstriction by any agent is usually 
potentiated by NPY. 8 NPY is thOUght to be involved in regulation of blood pressure, 
food intake, circadian rhythms, body temperature, sexual and motor activity, memory 
processing, and secretion of anterior pituitary hormones.5 Perhaps the most intriguing 
effect ofNPY is the modulation of Human Circadian Rhythms. 
Circadian Rhythms are daily rhythms in behavior and physiology. These 
rhythms have been found in all organisms studied, from plants to human beings. 
Circadian rhythms are produced by endogenous neuronal clocks that act to synchronize 
internal rhythms to environmental time cues like sunrise or sunset. The circadian clock in 
mammals is located in a region of the brain called the Suprachiasmatic Nucleus, or SeN. 
As indicated by its name it is located above the optic chiasm in the hypothalamus. The 
SCN acts in mammals to synchronize internal rhythmic processes to the daily rhythms in 
the environment. The entire functioning of an organism is ultimately controlled by the 
circadian clock making its modulation vital for adapting to changing conditions. 
In order to entrain Circadian rhythms to environmental cues the SCN has two 
avenues of input. The first input is a direct projection from the retina which provides the 
SCN with primary visual information about environmental lighting. 6 The retinal pathway 
is responsible for the entrianment of Circadian Rhythms to light-dark cycling.4 The 
other input to the SCN is an indirect projection from the retina through the lateral 
geniculate nucleus(LGN) of the thalamus and the intergeniculate leaflet(iGL) via the 
geniculohypothalamic tract( GHT). 6 This second pathway modulates the circadian clock 
on the impetus of a variety of environmental stimuli by releasing particular 
neurotransmitters. Understanding how these particular neurotransmitters affect the 
circadian clock can provide information about what particular environmental stimuli are 
causing the change. Therefore because the GHT cells are immunoreactive for NPY, and 
in rat brains they project predominantly to the ventrolateral region of the SCN 6, I have 
selected NPY to use for my study on Circadian Rhythnl entrainment. 
An understanding of the molecular structure ofNPY allows for a more detailed 
discussion subsequently about its cellular interaction with the circadian clock. NPY was 
discovered in porcine intestines by Tatemoto, and it is the subject of over 300 research 
publications.8 NPY shows much sequence homology with peptide YY and pancreatic 
polypeptide. Much like these two molecules NPY has a tyrosine at its N-terminus and its 
C-terminus. NPY is a 36 amino acid long peptide which possesses little variation from 
species to species.8 The gene for NPY has been elucidated by a number of labs, and a 
map of the complete prepro-NPY has been included in Figure 1. The two flanking 
regions of the peptide are enzymaticlly removed prior to the release ofNPY. The 30 
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amino acid sequence of 40-69 is highly conserved and plays an important honnonal role 
although it was once thought of as only a flanking sequence.8 The tertiary structure of 
NPY is an N-tenninal polyproline sequence(residues-8) and an amphiphilic a-helix(14-
28) connected with a type I ~-tum, creating a hairpin-like loop referred to as the PP-
fold. 1O The PP-fold may serve to bring the N-tenninus and the C-tenninus into close 
apposition, thereby enabling a receptor to recognize the signal epitopes of the ligand. to 
The molecular organization of the NPY has led researchers to important discoveries about 
its function. 
F or Example, the localization of NPY has been a well studied area thanks to the 
molecular elucidation. The most important areas of NPY localization are in sympathetic 
nervous system, the gut, and the brain.5 Other areas ofNPY localization include the bone 
marrow and spleen, but the role of NPY in these areas is much less well defined. 5 
Numerous studies though have shown that NPY is colocalized with norepiniphrine(NE) 
to sympathetic neurons and the adrenal medulla. Also, the parasympathetic system 
contains NPY colocalization with vasoactive intestinal peptide(VIP). Additionally, in the 
central nervous system, NPY is localized to a special class of nicotinamide adenine 
dinucleotide phosphate(NADPH) diaphorasse-containing cells thought to play an 
important role in Hunttington's disease. I However, the most important localization 
concerning circadian biology is the visual cortex. Here NPY containing neurons are 
found predominantly in the white matter. The areas of specific localization as discussed 
above are the GHT, iGL, and the RHT. Most important for this study is the NPY 
localized in the GHT which is a secondary input for circadian clock modulation. 
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NPY interacts with several subtypes of receptors including YI, Y2, and Y3. YI is 
defined as a receptor subtype that requires the entire molecule ofNPY for its activation. 10 
PYY can also activate the YI receptor, and has similar affinity as NPY for this receptor.s 
The Y I receptor studies indicate that it is concentrated primarily in the cortical regions of 
the brain, and that this receptor subtype is a glycoprotien with a molecular weight of 
about 70 kDa. lO It is thought that the receptor binds to the N and C terminus of NPY and 
the experiments performed with truncated versions ofNPY have supported this claim. 10 
Receptor binding studies have shown that the Y I subclass belongs to the G-coupled 
superfamily of receptors, and the interaction of NPY with second messenger systems 
through this receptor will be discussed in turn. 
Another of the receptor types is the Y2 subclass which can be activated with the 
N-terminus truncated forms ofNPY. The majority of the NPY receptors in the CNS are 
of this class including areas in the hypothalamus like the SCN. Studies of this receptor 
type show that the moleculeis a glycoprotien with a molecular weight of about 50 KDa. 
The Y 2 receptor interacts mainly with the C-terminus , and experiments have shown that 
it requires that the 25-36 region be intact. The Y2 receptor like YI receptor is thought to 
be G-protien coupled. 1 0 
The next receptor type, Y3 has been named based upon its inactivation by PPY. 
Unlike the first two types, type 3 shows little affinity for PPY. Type 3 also belongs to 
the G-coupled family, but has only 21 % homology with type 1. Type 3 is thought to 
interact with the cholinergic system since the NPY induced contraction of the rat distal 
colon can be blocked by atropine. 3 
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All of the receptor types mention above are coupled to G-proteins. In all the 
model systems pertusis toxin-sensitive of adenylate cyclase by NPY has been 
demonstrated. In many cell types ,including those in the SCN, the NPY activation alters 
intracellular Ca+2 concentrations generating inositol phosphates.3 The final effect of these 
signaling pathways is thought to turn "on" genes which are responsible for regulating the 
endogenous rhythm of the circadian clock, but these are only hypothesizes at this point. 
Another way in which NPY is thought to exert it effect on the SCN is coupled to 
G-proteins through the receptor-ligand interaction.7 It is though that most of the cells in 
the SCN exhibit 2 or possibly all 3 receptors types(YI-Y3). Action by these receptors 
turns on the alpha subunit of the G-protein hetero-trimer that then activates adenylate 
cyclase. Once activates adenylate cyclase causes a rise in intracellular levels of cAMP.7 
This rise in cAMP levels eventually turns on cAMP dependent kinase that can 
phosphorylate an number of enzymes important in altering the electrical activity in the 
SCN.7 Studies have been done applying NPY with a compound that prevents adenylate 
cyclase from producing cAMP to prove no modulation would occur.9 These studies 
proved correct in the second messenger system they chose for the NPY receptors because 
blocking cAMP blocked sensitivity to NPY even at CT 5-9, a time of proven NPY 
sensitivity . 
. The SCN has shown the ability to sustain nearly 24-hour oscillations in isolation 
from external time signals, but it can be reset by neuronal and endocrine inputs.6 The 
SCN receives the most important of its inputs, light, directly from the retina. Through 
light pulses the rhythm of mammal systems has been shown to change according to the 
5 
light cy1ce.5 Additionally several neurotransnlitters have been shown to nl0dulate the 
daily rhythms. For example seratonin has been shown in vitro to cause 2-3 hour shifts in 
the circadian rhythm. This phase shift resets the circadian clock so that the peak activity 
occurs at a different time. In this particular case the seratonin pulse causes a delay in the 
peak of2 to 3 hours. 
Like the other neurotransmitters NPY has been shown to modulate the activity of 
the circadian clock. Albers and Ferris have shown that NPY will phase-shift hamster 
behavioral rhythms in a manner similar to pulses of darkness: it induces phase-advances 
in the middle of the day and phase delays at night, when microinjected into the SCN.4 In 
vitro studies concentrating on the acute affects ofNPY on neuronal firing rates have 
shown a wide and variable response.4 Other studies have looked at the role ofNPY on 
phase of the circadian rhythm. These studies show that the phase of Circadian Rhythms 
can be manipulated by modulating the mammalian circadian clock, the SCN. 
In one study done by Dr. Marija Medanic from the University of Illinois the 
effects ofNPY in vitro on rat brains were analyzed.6 In the study NPY was briefly and 
focally applied to GHT projections sites of the SCN at different times across the circadian 
cycle. These applications were performed at 11 times across the cycle; Zietgeber 
Time(ZT) 0, 3,5, 7,8, 9,12, 15, 18,21 and 22 (ZT=O is lights on for the rat colony). The 
effect ofNPY on the phase of the pace maker was measured by recording the neuronal 
activity of a population of neurons in vitro one day after the brain slices were prepared. 
4-6 cells were measured each hour for 120 seconds, and 2 hour means were calculated.6 
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The electrical acticity n1easure at each time point represents a single cell. For this reason 
this particular type of recording is called single unit activity recording (SUA). 
This microdrop application ofNPY resulted in phase shifts of the electrical 
activity. The results indicated that there were two distinct times of sensitivity to NPY. 6 
During the middle of the day(ZT 5-9) phase shifts of more than 2 hours were induced, 
and similarly between ZT 21-24 application resulted in large advances in the rythums. 
The results of this study are included and plotted on Figure 2 in a phase response curve 
format. A phase response curve plots the times when drugs are applied, and shows how 
much the circadian clock is modulated in hours by charting the changes in the time of 
peak activity. Points above the x-axis represent advances, and points below the x-axis 
represent delays. 
Other studies have looked at the in vivo affects ofNPY applications. Dr. Kim 
Huhman injected hamsters with NPY and looked at how it affected their activity 
rhythms.4 In order to ascertain their activity rhythms the hamsters were provided with 
running wheels connected to a microswitch. The phase shifts quantified using linear 
regression revealed that the in vivo application too had a characteristic phase-response 
curve. The results from this study seemed to corroborate the findings of the in vitro 
applications. NPY application at CT 5-8 advanced the phase of the activity rhythm as 
much as 2.3 hours, but this study did not show sensitivity to the CT 21-24 applications 
like Dr. Medanic's. 
Dr. Shibata a researcher from Japan has done a similar study with NPY 
applications to that of Dr. Medanic. He also found that NPY applications near the middle 
7 
of the subjective day produced advances in the peak activity. However, he did not see the 
window of sensitivity during the evening( ZT 22) that Medanic found. His studies were 
conducted using a similar technique to Dr. Medanic, SUA recordings. His results are also 
plotted in the phase response curve in Figure 2. 
In Dr. Rebecca Prosser's lab at the University of Tennessee a different technique 
is used to measure the electrical activity associated with the circadian clock, and it is 
called multi-unit activity recording (MUA). The reason this technique is called multi unit 
is because the diameter of the wire is larger and it measures the activity from a population 
of cells simultaneously. I wanted to discover what the measured effects ofNPY 
applications would be using MUA recordings. Therefore I set out to first establish that 
the MUA recording was a valid measuring device by performing control experiments. 
Then I made NPY applications at ZT times 14, 19, and 22 to try and complete a phase 
response curve for NPY applications. 
To complete a control experiment the following method is used. First coronal 
brain slices were made from Sprage-Dawley adult male rats. These slices included the 
SCN , and were sized down for measurement. The slices were then transferred to a brain 
slice chamber. The slice chamber is maintained at 37°C, and perfused with Earle's 
balanced slat solution(EBBS) supplemented with glucose and pH buffer. Additionally 
the chamber is bubbled with a 950/0 02 - 50/0 C02 solution to help further mimic 
physiological conditions. Once the slices were in place the electrica1 activity was 
recorded using a 76 micron platinum/iridium wire coated with Teflon©. The electrical 
activity recorded represents the spontaneous action potentials generated with in a 
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population of neurons in the SCN. The recordings are done for two days and the activity 
of the second day is use for analysis. The second day activity can be recorded and 
analyzed to yield a time of peak activity which can be used as a marker. Thus, if the time 
of peak changes it can be taken to mean that the circadian clock has been reset. The data 
from the activity recordings are stored in a Datawave© application, and the results are 
plotted in histogram format. 
The control experiments were done to establish that the MUA recording technique 
could measure Circadian Rhythms. Results from all previous work showed that the time 
of peak activity should be at Zietgeber time 6(lpm). In my numerous control 
experiments I attempted to reproduce the results from previous experiments done by other 
researchers. Eventually my results agreed with the experts in the field, and the results are 
included in Figure 3. 
With the control experiments validating the MUA technique, NPYapplications 
were the next step in the project. The procedure for these experiments was similar to the 
method used for the controls. The only deviation is that at the appropriate selected time 
NPY was administered to the slice. It was applied by removing all the EBBS from the 
slice charrlber, and then replacing it with a solution of 1 micromolar NPY enriched 
EBBS. The NPY solution was left on for 1 hour, and then the normal media was replaced. 
The results form the experiments show that NPY does have an effect on the time 
of peak during the times tested. First, at ZT 14 the NPY application showed a 2-3 hour 
advance in the time of peak. However, the application at ZT 19 showed no effect on the 
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time of peak acticity. The data for the last point, ZT 22, was not obtained and is needed 
to complete the phase response curve 
Therefore several studies included in this discussion have shown that NPY has an 
effect on the circadian rhythm in mammalian systems. The results from my project seems 
to agree with the work of other labs. The MUA phase response curve is similar to the one 
obtained by Shibata, only shifted 1-2 hours later in the afternoon. Findings in the field of 
circadian clock modulation could have an impact on the world of neurotransmitter 
research, and on everyday problems. Because NPY modulates the circadian rhythm of 
mammals it can be used to manipulate the sleep wake cycle. Some people have a 
problem in which their clocks become reset outside of actual environmental changes 
resulting many times in insomnia, and other sleep disorders. Treatment with NPY at 
certain times of the day would be helpful because it resets the circadian clock. By 
causing an advance of about 2-3 hours the NPY application could reset a disrupted 
rhythm back to normal providing an appropriate sleep-wake cycle. Additionally, it could 
be used to modulate the circadian clocks of shift workers. By resetting the clock to a 
certain stimulus the time of peak activity could be manipulated to coincide with working 
hours. 
The characterization of how NPY is important in circadian biology encompasses 
many fields from protein chemistry to signal transduction. From these different field 
unique information can be gleaned to provide an overall picture of how NPY effects the 
circadian pacemaker, the SeN. The body of work that has been published concerning 
NPY confirms that it plays a regulatory role in the mammalian circadian system. While 
10 
NPY has not been shown to be essential for generating circadian rhythmicity, there is 
increasing evidence that it is an integral element of the circadian system, providing 
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Met Met Leu Gly Asn Lys Arg Met Gly Leu Cys Gly Leu 
Thr Leu Ala Leu S~r L~l! L~u Val Cys L~l! Gly Il~ L~l! 
-1 1 
Ala GIl! Gly Tyr Pro Ser Lys Pro Asp Asn Pro Gly Glu 
Asp Ala Pro Asp Asn Pro Gly Glu Asp Ala Pro Ala Glu 
Asp Met Ala Arg Tyr Tyr Ser Ala Leu Arg his Tyr lie 
Asn Leu lie Thr Arg Gin Arg Tyr Gly Lys Arg Ser Ser 
Pro Glu Thr Leu lIe Ser Asp Leu Met Arg Glu Ser Thr 
Glu Asn Asn Ala Pro Arg Thr Arg Leu Glu Asp Pro Ser 
69 
Met Trp 
Figure 1. The amino acid sequence of pre-proNPY; underlined=signal peptide, bold= functional NPY, and 
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Figure 2. The results from two representative control experiments. The top graph peaked 
@ ZT 5.3. The bottom Graph peaked @ ZT 6. 
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Figure 4. Results from representative NPY application experiments. The gray boxes 
represent when the NPY was applied. The top graph peak at ZT 4.2 and the bottom graph 
peaked @ ZT 3.75. 
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